Age-related macular degeneration (AMD) is a leading cause of vision loss, and those over the age of 75 have a nearly 30% risk of being affected. Stem cells now offer the opportunity to restore vision in these patients. Join Stanley Chang, MD (K.K. Tse and Ku Teh Ying Professor of Ophthalmology, Columbia University), Kapil Bharti, PhD (Senior Investigator, National Eye Institute), and Susan L. Solomon, JD (Founder and CEO, NYSCF Research Institute) as they discuss the cell replacement therapies for AMD now under development at NYSCF and the NIH, and their paths to the clinic.
Find out more at http://www.nyscf.org
